EUVIMEDEUVIMED entdecken
Crossref

CRTAC1 as a biomarker for osteoarthritis: Link to inflammation and microRNA regulation

Aneta Prokopcová, Jiří Baloun, Klára Mocová, Lucia Ondrejčáková, Tereza Kropáčková, Michal Tomčík, Olga Šléglová, Olga Růžičková, Rastislav Ballay, Petr Fulín, Jindřiška Gatterová, Eva Kriegová und 4 weitere

Osteoarthritis and Cartilage · 2026

DOI: 10.1016/j.joca.2026.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Osteoarthritis and Cartilage, 2026. Verfasst von Aneta Prokopcová und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic addr…. Hauptthemen laut MEDLINE: MicroRNAs, Synovial Fluid, Osteoarthritis, Knee, Calcium-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to evaluate the profile of CRTAC1, a cartilage-associated protein, in the synovial fluid (SF) and plasma of individuals with osteoarthritis (OA) compared to controls. We assessed CRTAC1's specificity, explored differences among OA subtypes, and examined the link between inflammation, CRTAC1, and miRNAs potentially regulating its expression. METHOD: A total of 555 individuals participated, including 68 paired SF and plasma samples from individuals with OA, 51 post-traumatic effusion controls (PT-controls), and 95 healthy controls (HC) for plasma analyses. Knee radiographs were evaluated using the Kellgren-Lawrence grading scale. CRTAC1 levels were measured by mass spectrometry and validated via Immunoquantitative (IQ)-ELISA. Pro-inflammatory 27-plex assays were also validated by IQ-ELISA, and miRNA sequencing was followed by digital PCR validation. RESULTS: CRTAC1 levels were significantly higher in OA SF (33×) and plasma (32×) compared to controls, with greater concentrations in plasma. CRTAC1 in SF, but not plasma, correlated with OA severity (β=0.5). Associations were also identified between CRTAC1 and eotaxin in SF (β=0.14) and plasma (β=0.09). miR-10a-5p (2.5×), miR-107 (38×), and miR-186-5p (9.3×) were downregulated in controls compared to OA and inversely associated with CRTAC1 in SF. CONCLUSIONS: CRTAC1 has emerged as a potential biomarker for OA, with SF levels associated to disease severity and inflammation. Additionally, the identified miRNAs may play a role in regulating CRTAC1, contributing to OA progression. Although further research is needed to understand the mechanism of CRTAC1 in OA and its therapeutic prospects, our results indicate its potential as a biomarker of OA severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsSynovial FluidOsteoarthritis, KneeCalcium-Binding ProteinsHumansBiomarkersFemaleMaleMiddle AgedAgedCase-Control StudiesInflammationSeverity of Illness IndexEnzyme-Linked Immunosorbent AssayAdult

Stichwörter der Autor:innen

BiomarkerCRTAC1Cartilage degenerationEotaxinMiRNAOsteoarthritisTherapy

Substanzen

MicroRNAsBiomarkersCalcium-Binding Proteins

Autor:innen und Institutionen

  • Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: prokopcova@revma.cz.
  • Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: baloun@revma.cz.
  • Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: mocova@revma.cz.
  • Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: ondrejcakova@revma.cz.
  • Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: kropackova@revma.cz.
  • Institute of Rheumatology, Prague, Czechia; Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czechia. Electronic address: tomcik@revma.cz.

Zitieren

APA

Prokopcová, A., Baloun, J., Mocová, K., Ondrejčáková, L., Kropáčková, T., Tomčík, M., Šléglová, O., Růžičková, O., Ballay, R., Fulín, P., Gatterová, J., Kriegová, E., Gallo, J., Pavelka, K., Vencovský, J., & Šenolt, L. (2026). CRTAC1 as a biomarker for osteoarthritis: Link to inflammation and microRNA regulation. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2026.01.004

Vancouver

Prokopcová A, Baloun J, Mocová K, Ondrejčáková L, Kropáčková T, Tomčík M, et al. CRTAC1 as a biomarker for osteoarthritis: Link to inflammation and microRNA regulation. Osteoarthritis and Cartilage. 2026. doi:10.1016/j.joca.2026.01.004

BibTeX
@article{Prokopcov2026,
  author = {Prokopcová, Aneta and Baloun, Jiří and Mocová, Klára and Ondrejčáková, Lucia and Kropáčková, Tereza and Tomčík, Michal and Šléglová, Olga and Růžičková, Olga and Ballay, Rastislav and Fulín, Petr and Gatterová, Jindřiška and Kriegová, Eva and Gallo, Jiří and Pavelka, Karel and Vencovský, Jiří and Šenolt, Ladislav},
  title = {CRTAC1 as a biomarker for osteoarthritis: Link to inflammation and microRNA regulation},
  journal = {Osteoarthritis and Cartilage},
  year = {2026},
  doi = {10.1016/j.joca.2026.01.004}
}
Kostenlos starten →